ChemoMetec AS's book value per share for the quarter that ended in Dec. 2024 was kr34.36.
During the past 12 months, ChemoMetec AS's average Book Value Per Share Growth Rate was 19.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 28.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 27.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 33.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of ChemoMetec AS was 49.90% per year. The lowest was -85.40% per year. And the median was 11.65% per year.
ChemoMetec AS's current price is kr460.60. Its book value per share for the quarter that ended in Dec. 2024 was kr34.36. Hence, today's PB Ratio of ChemoMetec AS is 14.18.
During the past 13 years, the highest P/B Ratio of ChemoMetec AS was 71.71. The lowest was 5.35. And the median was 14.98.
ChemoMetec AS Book Value per Share Historical Data
The historical data trend for ChemoMetec AS's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ChemoMetec AS's Book Value per Share
For the Medical Devices subindustry, ChemoMetec AS's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ChemoMetec AS's PB Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's PB Ratio distribution charts can be found below:
* The bar in red indicates where ChemoMetec AS's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
ChemoMetec AS (LTS:0DZ0) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
ChemoMetec AS Book Value per Share Related Terms
Thank you for viewing the detailed overview of ChemoMetec AS's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0DZ0 has been successfully added to your 